Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103757972> ?p ?o ?g. }
- W2103757972 endingPage "17" @default.
- W2103757972 startingPage "1" @default.
- W2103757972 abstract "Malignant gliomas are uncommon, but extremely lethal, cancers. Current standard-of-care includes surgery, radiation and chemotherapy, but recent research has generated a shift towards targeting the aberrant signal transduction components that underlie the pathogenesis of malignant gliomas. Protein kinases are a family of enzymes that are key elements in signal transduction-regulated cellular homeostasis subdivided based on their catalytic activity into tyrosine kinases and serine/threonine kinases. Protein kinases can be deregulated by several mechanisms, including genomic rearrangement, mutations of oncogenes or loss of tumour suppressor genes and overexpression or mutation of growth factor receptors to contribute to cancer initiation and maintenance. In malignant gliomas, several protein kinases are commonly over activated and may represent new therapeutic targets. Two main classes of agents targeting protein kinases are monoclonal antibodies and small-molecule inhibitors. In clinical trials, these molecularly targeted therapies have demonstrated limited efficacy as single agents in unselected malignant glioma patient populations. Several mechanisms of the failure of targeted agent monotherapies have been elucidated as new therapeutic strategies have emerged to overcome the resistance. Multi-targeted kinase inhibitors and combinations of single-targeted kinase inhibitors with one another or with traditional cytotoxics may increase treatment efficacy. Identification of biomarkers of response or resistance will be of paramount importance to enrich patients for specific targeted agents based on their genetic/molecular signature. In this review, the authors discuss the role of protein kinases in malignant glioma and how to target aberrant protein kinases with novel therapeutics." @default.
- W2103757972 created "2016-06-24" @default.
- W2103757972 creator A5021296578 @default.
- W2103757972 creator A5042871373 @default.
- W2103757972 creator A5084807750 @default.
- W2103757972 creator A5085537336 @default.
- W2103757972 date "2007-01-01" @default.
- W2103757972 modified "2023-09-26" @default.
- W2103757972 title "Malignant glioma drug discovery – targeting protein kinases" @default.
- W2103757972 cites W131042380 @default.
- W2103757972 cites W1584895714 @default.
- W2103757972 cites W1600720931 @default.
- W2103757972 cites W1639582946 @default.
- W2103757972 cites W1858161324 @default.
- W2103757972 cites W1968886293 @default.
- W2103757972 cites W1973143512 @default.
- W2103757972 cites W1974721606 @default.
- W2103757972 cites W1978922759 @default.
- W2103757972 cites W1979483425 @default.
- W2103757972 cites W1979933401 @default.
- W2103757972 cites W1981289962 @default.
- W2103757972 cites W1987797739 @default.
- W2103757972 cites W1993282564 @default.
- W2103757972 cites W1994309500 @default.
- W2103757972 cites W1995242599 @default.
- W2103757972 cites W1996811911 @default.
- W2103757972 cites W1998990808 @default.
- W2103757972 cites W1999737406 @default.
- W2103757972 cites W2006202974 @default.
- W2103757972 cites W2009996294 @default.
- W2103757972 cites W2014031706 @default.
- W2103757972 cites W2029219396 @default.
- W2103757972 cites W2029748067 @default.
- W2103757972 cites W2031749466 @default.
- W2103757972 cites W2033715459 @default.
- W2103757972 cites W2034269086 @default.
- W2103757972 cites W2041098455 @default.
- W2103757972 cites W2043696829 @default.
- W2103757972 cites W2044351212 @default.
- W2103757972 cites W2045538453 @default.
- W2103757972 cites W2048797151 @default.
- W2103757972 cites W2050026229 @default.
- W2103757972 cites W2052038529 @default.
- W2103757972 cites W2054251966 @default.
- W2103757972 cites W2057919501 @default.
- W2103757972 cites W2060097272 @default.
- W2103757972 cites W2064214863 @default.
- W2103757972 cites W2064283997 @default.
- W2103757972 cites W2067529967 @default.
- W2103757972 cites W2069653865 @default.
- W2103757972 cites W2070705072 @default.
- W2103757972 cites W2075216432 @default.
- W2103757972 cites W2075997152 @default.
- W2103757972 cites W2081217960 @default.
- W2103757972 cites W2093423704 @default.
- W2103757972 cites W2094224485 @default.
- W2103757972 cites W2094735628 @default.
- W2103757972 cites W2096287682 @default.
- W2103757972 cites W2098588666 @default.
- W2103757972 cites W2101781016 @default.
- W2103757972 cites W2102000647 @default.
- W2103757972 cites W2102339903 @default.
- W2103757972 cites W2104316901 @default.
- W2103757972 cites W2104743043 @default.
- W2103757972 cites W2104917184 @default.
- W2103757972 cites W2108247214 @default.
- W2103757972 cites W2108914190 @default.
- W2103757972 cites W2109467838 @default.
- W2103757972 cites W2110094917 @default.
- W2103757972 cites W2111399814 @default.
- W2103757972 cites W2111424734 @default.
- W2103757972 cites W2113788015 @default.
- W2103757972 cites W2114438728 @default.
- W2103757972 cites W2114632624 @default.
- W2103757972 cites W2117941094 @default.
- W2103757972 cites W2120878737 @default.
- W2103757972 cites W2121398618 @default.
- W2103757972 cites W2123902127 @default.
- W2103757972 cites W2124512686 @default.
- W2103757972 cites W2125096000 @default.
- W2103757972 cites W2125887187 @default.
- W2103757972 cites W2126372596 @default.
- W2103757972 cites W2126718734 @default.
- W2103757972 cites W2126783165 @default.
- W2103757972 cites W2130105793 @default.
- W2103757972 cites W2131351052 @default.
- W2103757972 cites W2133708161 @default.
- W2103757972 cites W2134442967 @default.
- W2103757972 cites W2137082827 @default.
- W2103757972 cites W2137551916 @default.
- W2103757972 cites W2137586969 @default.
- W2103757972 cites W2137600224 @default.
- W2103757972 cites W2138778824 @default.
- W2103757972 cites W2139994556 @default.
- W2103757972 cites W2140859993 @default.
- W2103757972 cites W2141977548 @default.
- W2103757972 cites W2142752401 @default.
- W2103757972 cites W2143737148 @default.